Big Brand Price Reductions Would Be Needed Without Rebates In Part D, Humana Warns

Insurer suggests manufacturers may not be willing to lower list prices enough to make up financial shortfalls in Medicare Part D that would be caused by restrictions on rebates.

Dollar sign made of pills on blue background

More from Pricing Debate

More from Market Access